Treatment and Dose Optimization in HR+/HER2- Early Breast Cancer
A comprehensive discussion on approaches to optimizing treatment selection and dosing in HR+/HER2- breast cancer.
Source: onclive.com
Stay updated with breaking news from Nrg Br007. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A comprehensive discussion on approaches to optimizing treatment selection and dosing in HR+/HER2- breast cancer.